Search
cefonicid (Monocid)
Tradename: Monocid. 2nd generation cephalosporin.
Indications:
- treatment of bacterial infections due to susceptible organisms
- lower respiratory tract infection
- pneumonia
- skin or soft tissue infection
- infectious arthritis, osteomyelitis
- prophylaxis for perioperative infection
- prosthetic arthroplasty
Dosage: 1-2 g IV/IM every 24 hours.
Antimicrobial activity:
- Streptococcus
- Streptococcus group A
- Streptococcus group B
- Streptococcus group C
- Streptococcus group G
- Streptococcus pneumonia
- Streptococcus viridans, milleri
- Staphylococcus aureus (MSSA)
- Staphylococcus epidermidis (+/-)
Gram negative
- Neisseria gonorrhoeae
- Neisseria meningitidis
- Moraxella catarrhalis
- Haemophilus influenzae
- Escherichia coli
- Klebsiella species
- Enterobacter species
- Proteus mirabilis
- Proteus vulgaris
- Providencia species
- Morganella species
- Morganella morganii [3]
- Citrobacter species (+/-)
- Aeromonas species (+/-)
Anaerobes
- Clostridium species
- Peptostreptococcus species
Interactions
drug interactions
drug adverse effects of cephalosporins
General
cephalosporin, 2nd generation
Properties
MISC-INFO: elimination route KIDNEY
pregnancy-category B
safety in lactation ?
Database Correlations
PUBCHEM correlations
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Sanford Guide to antimicrobial therapy 1997
- Deprecated Reference